A Phase II Study of Concurrent Carboplatin and Paclitaxel and Thoracic Radiotherapy for Completely Resected Stage II and IIIA Non-small Cell Lung Cancer
- 1 April 2007
- journal article
- research article
- Published by Elsevier in Journal of Thoracic Oncology
- Vol. 2 (4) , 287-292
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2005
- Randomized Clinical Trial of adjuvant chemotherapy with paclitaxel and carboplatin following resection in Stage IB Non-Small Cell Lung Cancer (NSCLC): Report of Cancer and Leukemia Group B (CALGB) Protocol 9633Journal of Clinical Oncology, 2004
- Cisplatin-Based Adjuvant Chemotherapy in Patients with Completely Resected Non–Small-Cell Lung CancerNew England Journal of Medicine, 2004
- Risk of Death From Intercurrent Disease Is Not Excessively Increased by Modern Postoperative Radiotherapy for High-Risk Resected Non–Small-Cell Lung CarcinomaJournal of Clinical Oncology, 2001
- Survival of Patients With Resected N2 Non–Small-Cell Lung Cancer: Evidence for a Subclassification and ImplicationsJournal of Clinical Oncology, 2000
- A controlled study of postoperative radiotherapy for patients with completely resected nonsmall cell lung carcinomaCancer, 1999
- Postoperative radiotherapy in non-small-cell lung cancer: systematic review and meta-analysis of individual patient data from nine randomised controlled trialsThe Lancet, 1998
- The role of post-operative radiotherapy in non-small-cell lung cancer: a multicentre randomised trial in patients with pathologically staged T1-2, N1-2, M0 diseaseBritish Journal of Cancer, 1996
- A New International Staging System for Lung CancerChest, 1986
- Sites of recurrence in resected stage I non-small-cell lung cancer: a guide for future studies.Journal of Clinical Oncology, 1984